Sionna Therapeutics
Small molecule therapeutics for cystic fibrosis
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 19 pending
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 19- PendingCompounds, Compositions, And Methods Of Using ThereofUSPTOApplication 18873248
- PendingMethods Of Treating Cftr-mediated Diseases Or DisordersUSPTOApplication 19193542
- PendingMethods Of Treating Cftr-mediated Diseases Or DisordersUSPTOApplication PCTUS2025018758
Show all 19 patent records
- Compounds, Compositions, And Methods Of Using ThereofOct 23, 2025 · Application 18873248Pending
- Methods Of Treating Cftr-mediated Diseases Or DisordersAug 14, 2025 · Application 19193542Pending
- Methods Of Treating Cftr-mediated Diseases Or DisordersApplication PCTUS2025018758Pending
- Compounds, Compositions, And Methods Of Using ThereofApplication PCTUS2024060181Pending
- NBD1 Modulators And Methods Of Using The SameApplication 63730742Pending
- Methods Of Treating Cftr-mediated Diseases Or DisordersApplication 63561958Pending
- NBD1 Modulators And Methods Of Using The SameApplication PCTUS2024018153Pending
- NBD1 Modulators And Methods Of Using The SameApplication PCTUS2024018145Pending
- NBD1 Modulators And Methods Of Using The SameApplication PCTUS2024018173Pending
- NBD1 Modulators And Methods Of Using The SameApplication PCTUS2024018148Pending
- Compounds, Compositions, And Methods Of Using The SameApplication 63610882Pending
- Methods Of Treating Cftr-mediated Diseases Or DisordersApplication PCTUS2023036487Pending
- Compounds, Compositions, And Methods Of Using ThereofApplication PCTUS2023073551Pending
- Compounds, Compositions, And Methods Of Using ThereofApplication PCTUS2023073543Pending
- Compounds, Compositions, And Methods Of Using ThereofApplication PCTUS2023073558Pending
- Compounds, Compositions, And Methods Of Using ThereofApplication PCTUS2023068239Pending
- Methods Of Treating Cftr-mediated Diseases Or DisordersApplication 63420934Pending
- Compounds, Compositions, And Methods Of Using ThereofApplication 63350970Pending
- NBD1 Modulators And Methods Of Using The SameApplication PCTUS2025059121Pending
Related companies, and why
- SUNNYLIFE PHARMA INC.Similar federal contract value in Biotech · null in contracts
- Remix TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Renasant BioSimilar federal contract value in Biotech · null in contracts
- NEOKERA, LLCSimilar federal contract value in Biotech · null in contracts
- CARDIOCREATE, INC.Similar federal contract value in Biotech · null in contracts
- NEONEURON, LLCSimilar federal contract value in Biotech · null in contracts
Press
Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for VertexFierceBiotech
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .